Carlo med
Danielle Murashige

Danielle Murashige

Cardiovascular Disease Fellow

1st year · University of Pennsylvania

ORCID
JourneyEducationResearchSources

Journey

Education, training and research through time.

  1. Undergraduate

    University of Virginia

  2. Combined degree

    University of Pennsylvania

  3. Residency

    Hospital of the University of Pennsylvania

  4. Fellowship

    University of Pennsylvania

  1. Observed in a 2015 publication
    ResearchSydney, Australia

    Research affiliation, Diabetes and Obesity Program[7]

    Garvan Institute of Medical Research

    A 2015 paper gives Murashige a Garvan author affiliation and a Penn present address. It does not establish an appointment title or duration.

  2. 2015

    1 attributed work

  3. 2018

    3 attributed works

  4. 2019

    1 attributed work

  5. 2020

    2 attributed works

  6. 2021
  7. 2022
  8. Estimated 2023-2026
    ResidencyPhiladelphia, Pennsylvania

    Internal Medicine Residency[4][8]

    Hospital of the University of Pennsylvania

    The 2023 residency match and transition into first-year Penn fellowship in 2026 bound a coherent 2023-2026 residency estimate. Murashige began Penn residency in the 2023 match cycle. She moved directly from residency into Penn cardiovascular fellowship. Penn does not state Murashige's individual residency appointment dates. The endpoints are year-precision estimates rather than exact dates.

    Penn's 2023 MSTP match list identifies Internal Medicine at Penn as Murashige's destination; the current fellowship roster independently names HUP as her residency program.

    • 2023 match·Matched to Penn Internal Medicine[8]
  9. 2025
  10. Estimated 2026-2029
    FellowshipPhiladelphia, Pennsylvania

    First-year Cardiovascular Disease Fellow[4][11]

    University of Pennsylvania

    A first-year fellow observed in 2026 within Penn's three-year structure corresponds to an estimated 2026 start and 2029 end at year precision. The roster's year label maps to the 2026 training year. Murashige follows the program's standard three-year sequence without interruption. Penn does not publish Murashige's individual appointment dates. The 2029 endpoint is an estimated program boundary, not a confirmed or expected award date.

    Penn places Murashige among first-year cardiovascular disease fellows. The displayed 2026-2029 span is estimated from that year label and the program's three-year structure.

  11. Dates unknown
    UndergraduateCharlottesville, Virginia

    Human Biology undergraduate education[10]

    University of Virginia

    UVA's Harris Lab identifies Murashige as an undergraduate in the Human Biology program but supplies no dates or exact degree title.

  12. Full attendance interval unknown
    Combined degreePhiladelphia, Pennsylvania

    MD-PhD education in Cell Biology, Physiology, and Metabolism[3][4][8]

    University of Pennsylvania

    Penn identifies Murashige as a combined-degree MD-PhD student in the CAMB Cell Biology, Physiology, and Metabolism program and Arany Lab. The source chronology distinguishes PhD defense, the 2022 graduate profile, return to medical school, and the 2023 residency match.

    • Completed 2022·Completed PhD in the CAMB Cell Biology, Physiology, and Metabolism program[3]
    • 2023 match·Matched to Penn Internal Medicine[8]

    Completed on 2021-07-15

    Graduate educationPhiladelphia, Pennsylvania

    PhD thesis defense in Cell and Molecular Biology[9]

    University of Pennsylvania

    Penn MSTP dates Murashige's CAMB thesis defense and names the thesis topic and mentor Zolt Arany.

Works appear by publication year. Their position does not establish where or when the underlying research was performed.